Pb-212-VMT-α-NET
212Pb-VMT-α-NET is the therapeutic analogue of the imaging agent 203Pb-VMT-α-NET [...]
Lu-177-LNC1010
177Lu-LNC1010 is a new radiolabeled drug targeting somatostatin receptors (sstr), [...]
Bi-213-DOTATOC
213Bi-DOTATOC is one alpha-labeled analogue of 90Y- and 177Lu-DOTATOC. This [...]
Lu-177-Oxodotreotide (Lutathera®)
177Lu-Oxodotreotide (177Lu-Lutathera®, 177Lu-DOTATATE) is a radiolabeled somatostatin analogue developed [...]
Lu-177-Satoreotide tetraxetan
177Lu-Satoreotide tetratexan (177Lu-OPS201, 177Lu-DOTA-JR11) is the lutetium-177 analogue of [...]
Re-188-P2045 (Tozaride)
188Re-P2045 (BAY86-5284, Tozaride) is a 11-amino acid proprietary somatostatin [...]
Lu-177-Edotreotide (Solucin®)
177Lu-Edotreotide (177Lu--Octreotide, 177Lu-Solucin®) is a radiolabeled somatostatin analogue developed [...]
Pb-212-DOTAMTATE
212Pb-DOTAMTATE (212Pb-AlphaMedix™) is a somatostatin analogue labeled with Lead-212 [...]
Y-90-OPS201 (SOMTher®)
90Y-OPS201 (90Y-DOTA-JR11, 90Y-SOMTher®) is a proprietary drug that specifically binds [...]
Y-90-DOTATOC (Edotreotide)
90Y-Edotreotide (90Y-DOTATOC, 90Y-Onalta®) is a drug which is actually developed [...]